{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:13:10Z","timestamp":1777356790189,"version":"3.51.4"},"reference-count":42,"publisher":"BMJ","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2001,1,4]]},"published-print":{"date-parts":[[2001,5,1]]},"abstract":"<jats:sec>\n                  <jats:title>AIM<\/jats:title>\n                  <jats:p>To evaluate the effectiveness of oral erythromycin as a prokinetic agent for the treatment of moderately severe gastrointestinal dysmotility in preterm very low birthweight infants.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec sec-type=\"methods\">\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>A prospective, double blind, randomised, placebo controlled study in a tertiary referral centre of a university teaching hospital was conducted on 56 preterm infants (&lt;\u20091500 g) consecutively admitted to the neonatal unit. The infants were randomly allocated by minimisation to receive oral erythromycin (12.5 mg\/kg, every six hours for 14 days) or an equivalent volume of placebo solution (normal saline) if they received less than half the total daily fluid intake or less than 75 ml\/kg\/day of milk feeds by the enteral route on day 14 of life. The times taken to establish half, three quarters, and full enteral feeding after the drug treatment were compared between the two groups. Potential adverse effects of oral erythromycin and complications associated with parenteral nutrition were assessed as secondary outcomes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Twenty seven and 29 infants received oral erythromycin and placebo solution respectively. The times taken to establish half, three quarters, and full enteral feeding after the drug treatment were significantly shorter in the group receiving oral erythromycin than in those receiving the placebo (p\u2009&lt;\u20090.05, p\u2009&lt;\u20090.05 and p\u2009&lt;\u20090.0001 respectively). There was also a trend suggesting that more infants with prolonged feed intolerance developed cholestatic jaundice in the placebo than in the oral erythromycin group (10<jats:italic>v<\/jats:italic> 5 infants). None of the infants receiving oral erythromycin developed cardiac dysrhythmia, pyloric stenosis, or septicaemia caused by multiresistant organisms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Oral erythromycin is effective in facilitating enteral feeding in preterm very low birthweight infants with moderately severe gastrointestinal dysmotility. Treated infants can achieve full enteral feeding 10 days earlier, and this may result in a substantial saving on hyperalimentation. However, until the safety of erythromycin has been confirmed in preterm infants, this treatment modality should remain experimental. Prophylactic or routine use of this medication for treatment of mild cases of gastrointestinal dysmotility is probably not warranted at this stage.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/fn.84.3.f177","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T06:40:22Z","timestamp":1027752022000},"page":"F177-F182","source":"Crossref","is-referenced-by-count":67,"title":["Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants"],"prefix":"10.1136","volume":"84","author":[{"given":"P C","family":"Ng","sequence":"first","affiliation":[{"name":"aDepartment of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, \n\nbDepartment of Microbiology, \n\ncCentre for Clinical Trials and Epidemiological Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K W","family":"So","sequence":"additional","affiliation":[{"name":"aDepartment of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, \n\nbDepartment of Microbiology, \n\ncCentre for Clinical Trials and Epidemiological Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K S C","family":"Fung","sequence":"additional","affiliation":[{"name":"aDepartment of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, \n\nbDepartment of Microbiology, \n\ncCentre for Clinical Trials and Epidemiological Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C H","family":"Lee","sequence":"additional","affiliation":[{"name":"aDepartment of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, \n\nbDepartment of Microbiology, \n\ncCentre for Clinical Trials and Epidemiological Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T F","family":"Fok","sequence":"additional","affiliation":[{"name":"aDepartment of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, \n\nbDepartment of Microbiology, \n\ncCentre for Clinical Trials and Epidemiological Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Wong","sequence":"additional","affiliation":[{"name":"aDepartment of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, \n\nbDepartment of Microbiology, \n\ncCentre for Clinical Trials and Epidemiological Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Wong","sequence":"additional","affiliation":[{"name":"aDepartment of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, \n\nbDepartment of Microbiology, \n\ncCentre for Clinical Trials and Epidemiological Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K L","family":"Cheung","sequence":"additional","affiliation":[{"name":"aDepartment of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, \n\nbDepartment of Microbiology, \n\ncCentre for Clinical Trials and Epidemiological Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A F B","family":"Cheng","sequence":"additional","affiliation":[{"name":"aDepartment of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, \n\nbDepartment of Microbiology, \n\ncCentre for Clinical Trials and Epidemiological Research"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2001,5,1]]},"reference":[{"key":"2025090511544426000_84.3.F177.1","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/bjs.1800811006","article-title":"Macrolides in roles beyond antibiotic therapy.","volume":"81","author":"Pilot","year":"1994","journal-title":"Br J Surg"},{"key":"2025090511544426000_84.3.F177.2","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199704000-00010"},{"key":"2025090511544426000_84.3.F177.3","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199709000-00018"},{"key":"2025090511544426000_84.3.F177.4","first-page":"A375","article-title":"Erythromycin exerts a prokinetic effect in patients with chronic idiopathic intestinal pseudoobstruction [abstract].","volume":"98","author":"Miller","year":"1990","journal-title":"Gastroenterology"},{"key":"2025090511544426000_84.3.F177.5","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(94)90069-8"},{"key":"2025090511544426000_84.3.F177.6","doi-asserted-by":"publisher","DOI":"10.1136\/fn.71.2.F128"},{"key":"2025090511544426000_84.3.F177.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199004123221502"},{"key":"2025090511544426000_84.3.F177.8","first-page":"A507","article-title":"Effect of acute and chronic administration of erythromycin on gastrointestinal motility in scleroderma patients [abstract].","volume":"104","author":"Fiorucci","year":"1993","journal-title":"Gastroenterology"},{"key":"2025090511544426000_84.3.F177.9","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800800726"},{"key":"2025090511544426000_84.3.F177.10","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199007000-00009"},{"key":"2025090511544426000_84.3.F177.11","first-page":"97","article-title":"Jejunal biopsy with Watson's capsule and erythromycin.","volume":"47","author":"Colombo","year":"1995","journal-title":"Minerva Pediatr"},{"key":"2025090511544426000_84.3.F177.12","first-page":"2011","article-title":"Erythromycin as a prokinetic agent: a prospective, randomized, controlled study of efficacy in nasoenteric tube placement.","volume":"89","author":"Stern","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"2025090511544426000_84.3.F177.13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1440-1754.1997.tb01018.x","article-title":"Erythromycin treatment for gastrointestinal dysmotility in preterm infants.","volume":"33","author":"Ng","year":"1997","journal-title":"J Paediatr Child Health"},{"key":"2025090511544426000_84.3.F177.14","first-page":"324","article-title":"Effect of erythromycin on feeding intolerance in very low birth weight infants: a preliminary observation.","volume":"39","author":"Su","year":"1998","journal-title":"Acta Paediatr Sin"},{"key":"2025090511544426000_84.3.F177.15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1442-200X.1994.tb03161.x","article-title":"Erythromycin improves gastrointestinal motility in extremely low birthweight infants.","volume":"36","author":"Kubota","year":"1994","journal-title":"Acta Paediatr Jpn"},{"key":"2025090511544426000_84.3.F177.16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000243954","article-title":"Erythromycin increases gastric antral motility in human premature infants.","volume":"63","author":"Tomomasa","year":"1993","journal-title":"Biol Neonate"},{"key":"2025090511544426000_84.3.F177.17","doi-asserted-by":"publisher","DOI":"10.1136\/fn.79.2.F105"},{"key":"2025090511544426000_84.3.F177.18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/00006454-199308000-00011","article-title":"Cardiac toxicity associated with intravenous erythromycin lactobionate: two case reports and a review of the literature.","volume":"12","author":"Farrar","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"2025090511544426000_84.3.F177.19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/00006454-199409000-00028","article-title":"Cardiac toxicity of intravenous erythromycin lactobionate in preterm infants.","volume":"13","author":"Gouyon","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"2025090511544426000_84.3.F177.20","unstructured":"Sande MA Mandell GL (1990) Antimicrobial agents. in Goodman and Gilman's the pharmacologic basis of therapeutics. eds Gilman AG Rall TW Nies AS (Pergamon, Elmsford, NY), 8th ed. pp 1130\u20131134."},{"key":"2025090511544426000_84.3.F177.21","first-page":"15","article-title":"Pharmacokinetics on intravenous erythromycin lactobionate.","volume":"8 (suppl 2)","author":"Parsons","year":"1980","journal-title":"J Int Med Res"},{"key":"2025090511544426000_84.3.F177.22","first-page":"9","article-title":"Erythromycin pharmacokinetics in man.","volume":"8 (suppl 2)","author":"Houin","year":"1980","journal-title":"J Int Med Res"},{"key":"2025090511544426000_84.3.F177.23","first-page":"120","article-title":"The use of erythromycin lactobionate to facilitate the postpyloric passage of tubes in children.","volume":"14","author":"Gouyon","year":"1992","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025090511544426000_84.3.F177.24","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90164-T"},{"key":"2025090511544426000_84.3.F177.25","doi-asserted-by":"crossref","first-page":"F212","DOI":"10.1136\/fn.79.3.F212","article-title":"Influence of erythromycin on establishment of feeding in preterm infants: observations from a randomised controlled trial.","volume":"79","author":"Stenson","year":"1998","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2025090511544426000_84.3.F177.26","doi-asserted-by":"publisher","DOI":"10.1136\/fn.78.1.F10"},{"key":"2025090511544426000_84.3.F177.27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2982.1998.00086.x"},{"key":"2025090511544426000_84.3.F177.28","doi-asserted-by":"publisher","DOI":"10.1136\/gut.43.3.395"},{"key":"2025090511544426000_84.3.F177.29","first-page":"G418","article-title":"Gastrokinetic effects of erythromycin: myogenic and neurogenic mechanisms of action in rabbit stomach.","volume":"269","author":"Parkman","year":"1995","journal-title":"Am J Physiol"},{"key":"2025090511544426000_84.3.F177.30","first-page":"G52","article-title":"Effects of erythromycin in the dog upper gastrointestinal tract.","volume":"263","author":"Holle","year":"1992","journal-title":"Am J Physiol"},{"key":"2025090511544426000_84.3.F177.31","first-page":"G355","article-title":"Gastrointestinal motor effects of erythromycin.","volume":"259","author":"Otterson","year":"1990","journal-title":"Am J Physiol"},{"key":"2025090511544426000_84.3.F177.32","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91097-N"},{"key":"2025090511544426000_84.3.F177.33","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90266-X"},{"key":"2025090511544426000_84.3.F177.34","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91103-B"},{"key":"2025090511544426000_84.3.F177.35","doi-asserted-by":"publisher","DOI":"10.1136\/gut.29.4.483"},{"key":"2025090511544426000_84.3.F177.36","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(89)80302-6"},{"key":"2025090511544426000_84.3.F177.37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2982.1989.tb00152.x","article-title":"Postnatal maturation of small intestinal motility in preterm infants and term infants.","volume":"1","author":"Amarnath","year":"1989","journal-title":"Journal of Gastrointestinal Motility"},{"key":"2025090511544426000_84.3.F177.38","doi-asserted-by":"publisher","DOI":"10.1007\/BF01489315"},{"key":"2025090511544426000_84.3.F177.39","doi-asserted-by":"publisher","DOI":"10.1016\/0167-0115(82)90005-2"},{"key":"2025090511544426000_84.3.F177.40","first-page":"G1046","article-title":"Enteral nutrients promote postnatal maturation of intestinal motor activity.","volume":"264","author":"Berseth","year":"1993","journal-title":"Am J Physiol"},{"key":"2025090511544426000_84.3.F177.41","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00260.x"},{"key":"2025090511544426000_84.3.F177.42","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1999.00364.x"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/fn.84.3.F177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T19:06:16Z","timestamp":1757099176000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/fn.84.3.F177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5,1]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2001,5,1]]},"published-print":{"date-parts":[[2001,5,1]]}},"alternative-id":["10.1136\/fn.84.3.F177"],"URL":"https:\/\/doi.org\/10.1136\/fn.84.3.f177","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5,1]]}}}